EMA and FDA strengthen collaboration on pharmacovigilance.
- Published in:
- 2014
- Publication type:
- Journal Article
Works matching IS 10109609 AND DT 2014 AND VI 28 AND IP 1
Results: 55
1
2
Implementation of the revised general monograph on parenteral preparations in The International Pharmacopoeia: Limits for the test for bacterial endotoxins (3.4)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
3
International Nonproprietary Names for Pharmaceutical Substances (INN). RECOMMENDED International Nonproprietary Names: List 71.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 71
- Publication type:
- Article
4
Methysergide-containing medicines: new restrictions.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 25
- Publication type:
- Article
5
Strontium ranelate: further restrictions due to cardiovascular risks.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 25
- Publication type:
- Article
6
Saxagliptin: possible risk of heart failure.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 25
- Publication type:
- Article
7
Lithium: hypercalcaemia and hyperparathyroidism.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 24
- Publication type:
- Article
8
Testosterone: possible risk of stroke and heart attack.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 24
- Publication type:
- Article
9
Emergency contraceptives - high bodyweight may reduce effectiveness.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 24
- Publication type:
- Article
10
Sodium phosphate products in high doses: severe dehydration.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 23
- Publication type:
- Article
11
Clopidogrel: rare reports of acquired haemophilia.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 23
- Publication type:
- Article
12
Estradiol-containing creams: new restrictions.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 23
- Publication type:
- Article
13
Acipimox: only to be used as additional or alternative treatment.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 22
- Publication type:
- Article
14
Subcutaneous epoetin alfa: contraindicated in Singapore in chronic kidney disease patients.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 22
- Publication type:
- Article
15
Glibenclamide: risk of hypoglycaemia in elderly and renal-impaired patients.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 22
- Publication type:
- Article
16
Methylphenidate: rare risk of long-lasting erections in males.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 22
- Publication type:
- Article
17
Amiodarone: pulmonary toxicity.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 21
- Publication type:
- Article
18
Clobazam: serious skin reactions.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 21
- Publication type:
- Article
19
Combined hormonal contraceptives and venous thromboembolism.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 21
- Publication type:
- Article
20
The International Generic Drug Regulators Pilot.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 3
- By:
- Publication type:
- Article
21
Metreleptin approved to treat rare metabolic disease.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 31
- Publication type:
- Article
22
Bedaquiline recommended for approval to treat multidrug-resistant tuberculosis.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 31
- Publication type:
- Article
23
Australia and New Zealand harmonization activities.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 29
- Publication type:
- Article
24
Trametinib and dabrafenib approved in combination for advanced melanoma.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 30
- Publication type:
- Article
25
Dapaglifozin approved for type 2 diabetes.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 30
- Publication type:
- Article
26
Umeclidinium and vilanterol approved for chronic obstructive pulmonary disease.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 30
- Publication type:
- Article
27
First adjuvanted vaccine for H5N1 avian influenza approved.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 29
- Publication type:
- Article
28
Droxidopa approved for neurogenic orthostatic hypotension.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 31
- Publication type:
- Article
29
Updated guidance for annual strain change of seasonal influenza vaccines.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 28
- Publication type:
- Article
30
Canada-US Common Electronic Submissions Gateway.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 28
- Publication type:
- Article
31
New partnership to strengthen regulatory systems.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 27
- Publication type:
- Article
32
WHO response to FDA findings at Ranbaxy's Toansa site.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 27
- Publication type:
- Article
33
Regulatory action against Ranbaxy's Toansa facility.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 27
- Publication type:
- Article
34
Tafenoquine receives FDA Breakthrough Therapy designation.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 27
- Publication type:
- Article
35
EMA and FDA collaborate on bioequivalence inspections.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 26
- Publication type:
- Article
36
Regulatory options in the fight against antimicrobial resistance.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 26
- Publication type:
- Article
37
Annual ATC/DDD Methodology course.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 34
- Publication type:
- Article
38
Report calls for cooperation to strengthen post-market surveillance systems.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 34
- Publication type:
- Article
39
Medicines Patent Pool and Bristol- Myers Squibb sign agreement.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 33
- Publication type:
- Article
40
Who are the originators of innovative medicines in the EU?
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 33
- Publication type:
- Article
41
AIDS drugs for all: how global advocacy transformed pharmaceutical markets.
- Published in:
- 2014
- Publication type:
- Book Review
42
WHO Prequalification: A quiet revolution in global public health.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 32
- Publication type:
- Article
43
Revision of general monograph: Suppositories.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 45
- By:
- Publication type:
- Article
44
World malaria report: financing needed to sustain major progress.
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 32
- Publication type:
- Article
45
Technetium (<sup>99m</sup>Tc) exametazime complex injection.
- Published in:
- 2014
- By:
- Publication type:
- Instruction
46
RADIOPHARMACEUTICALS: Sodium iodide (<sup>131</sup>I) solution.
- Published in:
- 2014
- By:
- Publication type:
- Instruction
47
Revision of method of analysis: 5.4 Disintegration test for suppositories and rectal capsules.
- Published in:
- 2014
- By:
- Publication type:
- Instruction
48
Revision of method of analysis: 5.3 Disintegration test for tablets and capsules.
- Published in:
- 2014
- By:
- Publication type:
- Instruction
49
Thallous (<sup>201</sup>Tl) chloride injection.
- Published in:
- 2014
- By:
- Publication type:
- Instruction
50
Implementation of the revised general monograph on parenteral preparations in The International Pharmacopoeia: Limits for the test for bacterial endotoxins (3.4).
- Published in:
- WHO Drug Information, 2014, v. 28, n. 1, p. 41
- By:
- Publication type:
- Article